Company Corbus Pharmaceuticals Holdings, Inc.
Equities
CRBP
US21833P3010
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.62 USD | -2.57% | +9.85% | +605.13% |
Business Summary
Number of employees: 19
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01/13/01 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 11/14/11 |
Chief Tech/Sci/R&D Officer | 50 | 28/02 | |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 01/14/01 |
Avery Catlin
BRD | Director/Board Member | 75 | 01/14/01 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01/13/01 |
John Jenkins
BRD | Director/Board Member | 66 | 05/18/05 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 08/19/08 |
Yong Ben
BRD | Director/Board Member | 50 | 01/23/01 |
Peter Salzmann
BRD | Director/Board Member | 56 | 06/20/06 |
Anne Altmeyer
BRD | Director/Board Member | 59 | 20/22/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,686,693 | 10,434,476 ( 97.64 %) | 0 | 97.64 % |
Company contact information
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive Second floor
02062, Norwood
+617 963 0100
http://www.corbuspharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+605.13% | 460M | |
+3.37% | 108B | |
+10.73% | 104B | |
+1.28% | 22.33B | |
-12.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.85% | 17.64B | |
+4.88% | 14.05B | |
+34.36% | 12.51B |
- Stock Market
- Equities
- CRBP Stock
- Company Corbus Pharmaceuticals Holdings, Inc.